Predictive Model of Recovery in Patients With Chronic Nonspecific Neck Pain Undergoing Manual Therapy and Exercise

Sponsor
Universidade Nova de Lisboa (Other)
Overall Status
Unknown status
CT.gov ID
NCT03562338
Collaborator
(none)
80
2
7.7

Study Details

Study Description

Brief Summary

The aim of this study is to develop a predictive model to identify which patients with chronic nonspecific neck pain are more likely to benefit from manual therapy and exercise program, or usual care.

Condition or Disease Intervention/Treatment Phase
  • Other: Manual Therapy and Exercise (Physiotherapy Intervention)
  • Other: Usual Care (Physiotherapy Intervention)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Screening
Official Title:
Modelo Preditivo Para os Resultados de Sucesso Com um Programa Combinado de Terapia Manual e exercício em indivíduos Com Dor Cervical crónica de Origem não-especifica
Anticipated Study Start Date :
Jun 11, 2018
Anticipated Primary Completion Date :
Feb 1, 2019
Anticipated Study Completion Date :
Feb 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Manual Therapy and Exercise

Other: Manual Therapy and Exercise (Physiotherapy Intervention)
Participants in this group will receive a 6-weeks program of mobilization and progressive exercise for the neck flexors, 2 times a week.

Active Comparator: Usual Care

Other: Usual Care (Physiotherapy Intervention)
Participants in this group will receive usual care in physiotherapy during the 6-weeks period.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in Neck Pain Intensity as measured by the Numeric pain rating scale (NRPS) at 3 weeks. [3 weeks]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥2 point in NRPS (range: 0 - 10 points).

  2. Change from baseline in Neck Pain Intensity as measured by the Numeric pain rating scale (NRPS) at 6 weeks. [6 weeks]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥2 point in NRPS (range: 0 - 10 points).

  3. Change from baseline in Neck Pain Intensity as measured by the Numeric pain rating scale (NRPS) at follow-up 3 months. [Follow-up 3 months]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥2 point in NRPS (range: 0 - 10 points).

  4. Change from baseline in Neck Disability as measured by the Neck Disability Index (NDI) at 3 weeks. [3 weeks]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥27% in NDI (range: 0-50 and higher scores are indicative of more disability).

  5. Change from baseline in Neck Disability as measured by the Neck Disability Index (NDI) at 6 weeks. [6 weeks]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥27% in NDI (range: 0-50 and higher scores are indicative of more disability).

  6. Change from baseline in Neck Disability as measured by the Neck Disability Index (NDI) at follow-up 3 months. [Follow-up 3 months]

    The change will be defined on the Minimal Clinically Important Difference in treatment response defined as a decrease of ≥27% in NDI (range: 0-50 and higher scores are indicative of more disability).

Secondary Outcome Measures

  1. Clinical Important Treatment response in global perceived recovery as measured by Patient's Global Impression of Change Scale at 3 weeks [3 weeks]

    The clinically Important treatment response in global perceived recovery was defined as a value of ≥5 in Patient's Global Impression of Change Scale (range: 1-7 Likert Scale)

  2. Clinical Important Treatment response in global perceived recovery as measured by Patient's Global Impression of Change Scale at 6 weeks [6 weeks]

    The clinically Important treatment response in global perceived recovery was defined as a value of ≥5 in Patient's Global Impression of Change Scale (range: 1-7 Likert Scale)

  3. Clinical Important Treatment response in global perceived recovery as measured by Patient's Global Impression of Change Scale at follow-up 3 months [Follow-up 3 months]

    The clinically Important treatment response in global perceived recovery was defined as a value of ≥5 in Patient's Global Impression of Change Scale (range: 1-7 Likert Scale)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic nonspecific neck pain at least 3 months, defined as pain in the cervical region without a specific anatomopathological diagnosis;

  • Adults between 18 and 65 years of age and literate in Portuguese;

Exclusion Criteria:
  • History of cervical trauma and/or history of surgery in the prior 6 months;

  • Clinical signs of infection, tumor, neurological, inflammatory or systemic diseases;

  • Pregnancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universidade Nova de Lisboa

Investigators

  • Principal Investigator: Lúcia Domingues, Nova Medical School | Faculdade de Ciências Médicas - Universidade Nova de Lisboa

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universidade Nova de Lisboa
ClinicalTrials.gov Identifier:
NCT03562338
Other Study ID Numbers:
  • NOVA.MS|FCM-UNL
First Posted:
Jun 19, 2018
Last Update Posted:
Jun 19, 2018
Last Verified:
Jun 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universidade Nova de Lisboa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 19, 2018